Form 4: Thermo Fisher EVP Sells TMO Shares Under 10b5-1 Plan

Thermo Fisher Scientific Executive Vice President Gianluca Pettiti sold 400 shares of common stock for $574.15 per share as part of a pre-arranged trading plan.

Summary

• Gianluca Pettiti, Executive Vice President of Thermo Fisher Scientific Inc. (TMO), reported the sale of common stock.
• The transaction involved the disposition of 400 shares of common stock.
• The shares were sold at a price of $574.15 per share.
• The sale occurred on October 24, 2025.
• Following this transaction, Mr. Pettiti directly beneficially owns 21,152.223 shares of common stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Pettiti on February 10, 2025.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged Rule 10b5-1 trading plan, which is generally considered a neutral event as it does not typically signal new information about the company's performance or outlook.

Positives

• NA

Negatives

• NA

Risks

• NA

Future Outlook

NA

Management Comments

• NA

Industry Context

NA

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: Minor impact as it is a routine, pre-planned insider sale, not indicative of a change in company fundamentals.

Next Steps

• NA

Key Dates

Recommendation

The reported insider sale by an Executive Vice President is a routine transaction executed under a pre-arranged Rule 10b5-1 trading plan. This type of transaction is generally not considered indicative of a change in the company's fundamental outlook or a signal for investors to alter their positions. Therefore, a 'hold' recommendation is appropriate as this filing does not provide new information to warrant a change in investment strategy.

Keywords

Thermo Fisher Scientific, TMO, Insider Trading, Form 4, Stock Sale, Gianluca Pettiti, Executive Vice President, 10b5-1 Plan